{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:43:45Z","timestamp":1771008225654,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ejogrb.2020.12.024","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T19:39:12Z","timestamp":1608147552000},"page":"88-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Patients with higher anti-M\u00fcllerian hormone levels from POSEIDON group 4 benefit from GnRH-agonist long protocol: A retrospective study"],"prefix":"10.1016","volume":"257","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6515-7453","authenticated-orcid":false,"given":"Luxin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanwen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canquan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2020.12.024_bib0005","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/humupd\/dmw001","article-title":"Trends in \u2018poor responder\u2019research: lessons learned from RCTs in assisted conception","volume":"22","author":"Papathanasiou","year":"2016","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0010","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.fertnstert.2011.09.048","article-title":"A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel?","volume":"96","author":"Polyzos","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0015","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.rbmo.2015.03.002","article-title":"How to define, diagnose and treat poor responders? Responses from a worldwide survey of IVF clinics","volume":"30","author":"Patrizio","year":"2015","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.12.024_bib0020","first-page":"CD004379","article-title":"Bhattacharya S.Interventions for \u201cpoor responders\u201d to controlled ovarian hyper stimulation(COH) in in-vitro fertilisation (IVF)","author":"Pandian","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0025","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u201cpoor response\u201d to ovarian stimulation for in vitro fertilization: the bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0030","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/humrep\/deu135","article-title":"Implementing the ESHRE\u2019 poor responder\u2019 criteria in research studies: methodological implications","volume":"29","author":"Papathanasiou","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0035","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.fertnstert.2011.09.051","article-title":"Poor responders: still a problem","volume":"96","author":"Frydman","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0040","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1093\/humrep\/deu139","article-title":"The Bologna criteria for the definition of poor ovarian responders: is there a need for revision?","volume":"29","author":"Ferraretti","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0045","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13048-015-0204-9","article-title":"The bologna criteria for poor ovarian response: a contemporary critical appraisal","volume":"8","author":"Younis","year":"2015","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0050","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.rbmo.2017.03.009","article-title":"Live birth rates in various subgroups of poor ovarian responders fulfilling the bologna criteria","volume":"34","author":"Bozdag","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0055","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1093\/humrep\/des118","article-title":"The bologna criteria for poor ovarian response; has the job been accomplished?","volume":"27","author":"Younis","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0060","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1093\/humrep\/dew167","article-title":"Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor polymorphism p.N680S: a pharmacogenetic study","volume":"31","author":"Simoni","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0065","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dex208","article-title":"Efficacy and safety of follitropin alfa\/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders","volume":"32","author":"Humaidan","year":"2017","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.12.024_bib0070","doi-asserted-by":"crossref","first-page":"24","DOI":"10.23736\/S0031-0808.18.03511-5","article-title":"Novel approaches for diagnosis and management of low prognosis patients in assisted reproductive technology: the POSEIDON concept","volume":"61","author":"Conforti","year":"2019","journal-title":"Panminerva Med"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0075","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3389\/fendo.2019.00614","article-title":"Management strategies for POSEIDON groups 3 and 4","volume":"10","author":"Haahr","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0080","doi-asserted-by":"crossref","first-page":"e0207081","DOI":"10.1371\/journal.pone.0207081","article-title":"GnRH agonist long protocol versus GnRH antagonist protocol for various aged patients with diminished ovarian reserve: a retrospective study","volume":"13","author":"Huang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0085","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/humrep\/dev336","article-title":"Cumulative live birth rates after one or more complete cycles of IVF: a population-based study of linked cycle data from 178,898 women","volume":"31","author":"McLernon","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0090","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1093\/humrep\/der240","article-title":"Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF","volume":"26","author":"Pu","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0095","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.fertnstert.2013.09.035","article-title":"Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial","volume":"101","author":"Sunkara","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0100","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1093\/humrep\/der240","article-title":"Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF","volume":"26","author":"Pu","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.fertnstert.2013.09.035","article-title":"Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial","volume":"101","author":"Sunkara","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0110","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmx017","article-title":"GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type","volume":"23","author":"Lambalk","year":"2017","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0115","first-page":"2703","article-title":"Cumulative live birth rate: time for a consensus?","volume":"30","author":"Maheshwari","year":"2015","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.12.024_bib0120","first-page":"556","article-title":"Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols","volume":"32","author":"Toftager","year":"2017","journal-title":"Hum Reprod"},{"issue":"10","key":"10.1016\/j.ejogrb.2020.12.024_bib0125","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s10815-013-0077-z","article-title":"Determining an anti-Mullerian hormone cutoff level to predict clinical pregnancy following in vitro fertilization in women with severely diminished ovarian reserve","volume":"30","author":"Merhi","year":"2013","journal-title":"J Assist Reprod Genet"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.12.024_bib0130","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmu003","article-title":"The predictive accuracy of anti-Mullerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature","volume":"20","author":"Iliodromiti","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0135","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice","volume":"20","author":"La Marca","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0140","first-page":"370","article-title":"Conventional ovarian stimulation and single embryo transfer for IVF\/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?","volume":"31","author":"Drakopoulos","year":"2016","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.12.024_bib0145","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12958-018-0342-1","article-title":"Individualized controlled ovarian stimulation in expected poor-responders: an update","volume":"16","author":"Haahr","year":"2018","journal-title":"Rep. Boil. Endocrinol.: RB&E."},{"issue":"6","key":"10.1016\/j.ejogrb.2020.12.024_bib0150","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept","volume":"105","author":"Alviggi","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0155","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3389\/fendo.2019.00814","article-title":"The POSEIDON criteria and its measure of success through the eyes of clinicians and embryologists","volume":"10","author":"Esteves","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0160","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.rbmo.2012.12.009","article-title":"Effect of co-incubation of oocytes with a decreasing number of spermatozoa on embryo quality","volume":"26","author":"Khoudje","year":"2013","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2020.12.024_bib0165","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0015-0282(00)00518-5","article-title":"Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer","volume":"73","author":"Gardner","year":"2000","journal-title":"Fertil Steril"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211520308083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211520308083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:49:28Z","timestamp":1759556968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211520308083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":33,"alternative-id":["S0301211520308083"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2020.12.024","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patients with higher anti-M\u00fcllerian hormone levels from POSEIDON group 4 benefit from GnRH-agonist long protocol: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2020.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}